Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Apr 9, 2010

Premium

PerkinElmer this week said it has expanded its "no wash" Amplified Luminescent Proximity Homogeneous Assay, or ALPHA, technology portfolio, to include 28 new cell signaling pathway and biomarker research assay kits.

The new offerings include nine AlphaScreen SureFire immunoassay kits, which contain endogenous cellular kinase assays for research into the expression and function of particular phosphoproteins within cellular pathways.

Also new is the AlphaLisa immunoassay for the study of biomarkers, which offers "more options for human and mouse proteins," PerkinElmer said in a statement.


Aushon BioSystems this week launched its human multiplex biomarker panels for the quantification of seven biomarkers associated with drug-induced vascular injury.

The Human Vascular Injury Panels include E-selectin; P-selectin; ICAM-3: thrombomodulin; ICAM-1: VCAM-1; and SAA.

The panels, which were developed using Aushon's SearchLight protein array technology, are validated for analysis of serum, plasma, and tissue culture samples, the company said in a statement.


Premier Biosoft International this week launched SimGlycan version 2.90.

The updated program can analyze up to 500 peaks at a time, and users can create a search parameter template to apply all the peak list datasets and generate a comprehensive report of findings, the company said in a statement.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.